⚡ Flash Summary
Liven Pharma Limited has announced a book closure for the purpose of issuing right shares. The share transfer books will be closed on November 27th, 2025 to determine shareholder entitlement. This action aligns with the company’s previously announced plans to issue right shares, as communicated on September 12th, 2025. Shareholders must ensure that share transfers are completed and received by the Company’s Share Registrar by the close of business on November 26th, 2025, to be eligible for the right shares.
📌 Key Takeaways
- 🗓️ Book closure announced for right shares: November 27th, 2025.
- 📢 Announcement references prior communication on September 12th, 2025.
- ⏳ Last date for transfers: November 26th, 2025.
- 🏢 Share registrar: M/S F.D. Registrar Services SMC (Pvt.) Ltd.
- 📍 Registrar address: 1705, 17th Floor, Saima Trade Tower A, I.I. Chundrigar Road, Karachi.
- ✔️ Compliance with PSX Rule Book: Clause 5.6.9 (b).
- 📰 Publication in Pakistan Observer and Daily Pakistan on November 19th, 2025.
- 💼 Right shares issuance to strengthen capital base.
- 🔒 Book closure impacts share trading temporarily.
- 📈 Potential increase in outstanding shares.
- 🤔 Dilution of existing shareholders if rights are not exercised.
- 🌱 Capital infusion could fund expansion plans.
- 📜 Terms and ratio of right shares not detailed in this notice.
🎯 Investment Thesis
Based solely on the book closure announcement for right shares, a HOLD recommendation is appropriate. While the capital infusion could potentially benefit Liven Pharma’s long-term growth prospects, the lack of details regarding the terms of the right shares and the intended use of funds makes it difficult to assess the investment opportunity. Further information is required to determine a precise price target. The time horizon is dependent on the company’s execution of its growth strategy with the raised capital.
Disclaimer: AI-generated analysis. Not financial advice.